Convergent Bio
PrivateLast Round
Accelerator
Aug 22, 2024
Company Overview
Convergent Bio operates in Healthcare & Life Sciences and is based in Dover, Delaware. Its latest recorded funding round was an Accelerator round in August 2024.
Convergent Bio is an agtech company that develops sustainable agriculture technologies using a multidisciplinary approach of bioconvergence, biodelivery, and biosystems.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share, Usage-Based SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convergent Bio Comparables
Compare Convergent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chan Zuckerberg Biohub | 84% | |
| Chai Discovery | 79% | |
| Cradle | 78% |
For institutional investors. Book with your work email.
Convergent Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Convergent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Topeka | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2024
Received funding from Plug and Play Topeka.
For institutional investors. Book with your work email.
Convergent Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Convergent Bio's valuation, stock price, and market status.
Is Convergent Bio a public or private company?
Convergent Bio is a private company.
What is the current stock price of Convergent Bio?
Convergent Bio is a private company, so its shares have no public market price. Caplight tracks Convergent Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Convergent Bio worth (valuation)?
Valuation information for Convergent Bio is not publicly available.
Can I buy Convergent Bio stock?
Convergent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Convergent Bio's last funding round?
Convergent Bio's most recent funding round was Accelerator on August 22, 2024.
Who are the main investors in Convergent Bio?
Key investors in Convergent Bio include Plug and Play Topeka.
Will Convergent Bio IPO soon?
No public IPO plans have been announced for Convergent Bio.
How can I track Convergent Bio secondary market activity?
Caplight tracks bids, offers, and trades in Convergent Bio's shares on secondary markets.